Metraipolis › archive › dc_640f750cf53e
Metformin enhances alpelisib sensitivity in HER2+ breast cancer by suppressing cancer stemness and oncogenic signaling — Europe PMC PMID:41347072
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41347072
- DOI
- 10.3389/fonc.2025.1631415
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T10:15:27.492Z
- SHA-256 of the archived text
0ae8ddaaa7cfdd24e15d2f3397f80b01194f63e872a7349e07fb3dd775272142- Stable URL of this page
https://metraipolis.com/documento/dc_640f750cf53e
How to cite
Metformin enhances alpelisib sensitivity in HER2+ breast cancer by suppressing cancer stemness and oncogenic signaling — Europe PMC PMID:41347072 — Europe PMC (en), https://europepmc.org/article/MED/41347072 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_640f750cf53e (Metraipolis archive dc_640f750cf53e, sha256 0ae8ddaaa7cfdd24e15d2f3397f80b01194f63e872a7349e07fb3dd775272142)
BibTeX
@misc{dc640f750cf53e,
title = {Metformin enhances alpelisib sensitivity in HER2+ breast cancer by suppressing cancer stemness and oncogenic signaling — Europe PMC PMID:41347072},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41347072},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_640f750cf53e; sha256 0ae8ddaaa7cfdd24e15d2f3397f80b01194f63e872a7349e07fb3dd775272142},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41347072. Agents can read the archived copy with the MCP tool read_document.